You can withdraw from that? The effects of abrupt discontinuation of medications

Orthopedics

Volumn 29, Issue 5, 2006, Pages 413-417

  Papadopoulos, Stella ^a   Cook, Aaron M ^a,b  

^a UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; ANTIDEPRESSANT AGENT; ANTIHYPERTENSIVE AGENT; BENZODIAZEPINE DERIVATIVE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CITALOPRAM; CLONIDINE; CORTICOSTEROID; DEXAMETHASONE; EPHEDRA EXTRACT; FLUOXETINE; FLUVOXAMINE; GARLIC EXTRACT; GINKGO BILOBA EXTRACT; GINSENG EXTRACT; HERBACEOUS AGENT; HYDROCORTISONE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; METHYLPREDNISOLONE; OPIATE AGONIST; PAROXETINE; PREDNISONE; SELECTIVE ESTROGEN RECEPTOR MODULATOR; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TETRACOSACTIDE; VALERIAN;

ABDOMINAL PAIN; ADRENAL CORTEX INSUFFICIENCY; ADRENAL INSUFFICIENCY; ADRENAL SUPPRESSION; AGITATION; ANAMNESIS; ANOREXIA; ANXIETY DISORDER; ARTHRALGIA; ARTICLE; AUDITORY HALLUCINATION; BLEEDING; CONVULSION; DELIRIUM TREMENS; DIZZINESS; DRUG FEVER; DRUG HALF LIFE; DRUG INDUCED HEADACHE; DRUG MECHANISM; DRUG USE; DRUG WITHDRAWAL; EUPHORIA; FATIGUE; HEART MUSCLE ISCHEMIA; HOME CARE; HOSPITAL ADMISSION; HUMAN; HYPERTENSION; HYPERTENSIVE CRISIS; HYPOTENSION; LETHARGY; MAJOR DEPRESSION; MUSCLE CRAMP; MUSCLE TWITCH; NAUSEA; NONHUMAN; PANIC; PARESTHESIA; RESTLESSNESS; SEDATION; SEIZURE; SHOCK; SIDE EFFECT; SOMNOLENCE; STROKE; SWEATING; TACHYCARDIA; TREMOR; VISUAL HALLUCINATION; VOMITING; WITHDRAWAL SYNDROME;

EID: 33745270798     PISSN: 01477447     EISSN: None     Source Type: Journal    
DOI: 10.3928/01477447-20060501-16     Document Type: Article

References (23)

1. Tam VC, Knowles SR, Cornish PL, Fine N, Marchesano R, Etchells EE. Frequency, type and clinical importance of medication history errors at admission to hospital: a systematic review. CMAJ. 2005; 173:510-515.
2. Using medication reconciliation to prevent errors. Sentinel Event Alert. 2006; 35:14.
3. Haddad PM. Antidepressant discontinuation syndromes. Drug Saf. 2001; 24:183-197.
4. Maes M. The immunoregulatory effects of antidepressants. Hum Psychopharmacol. 2001; 16:95-103.
5. Judge R, Parry MG, Quail D, Jacobson JG. Discontinua- tion symptoms: comparison of brief interruption in fluoxetine and paroxetine treatment. Int Clin Psychopharmacol. 2002; 17:217-225.
6. Mehta JL, Lopez LM. Rebound hypertension following abrupt cessation of clonidine and metoprolol. Treatment with labetalol. Arch Intent Med. 1987; 147:389-390.
7. Simic J, Kishineff S, Goldberg R, Gifford W. Acute myocardial infarction as a complication of clonidine withdrawal. J Emerg Med. 2003; 25:399-402.
8. Hansson L, Hunyor SN, Julius S, Hoobler SW. Blood pressure crisis following withdrawal of clonidine (Catapres, Catapresan), with special reference to arterial and urinary catecholamine levels, and suggestions for acute management. Am Heart J. 1973; 85:605-610.
9. Cunningham FE, Baughman VL, Peters J, Laurito CE. Comparative pharmacokinetics of oral versus sublingual clonidine. J Clin Anesth. 1994; 6:430-433.
10. Frishman WH. Beta-adrenergic blocker withdrawal. Am J Cardiol. 1987; 13:26F-32F.
11. Pass SE, Simpson RW. Discontinuation and reinstitution of medications during the perioperative period. Am J Health Syst Pharm. 2004; 61:899-912; quiz 913-894.
12. Axelrod L. Perioperative management of patients treated with glucocorticoids. Endocrinol Metab Clin North Am. 2003; 32:367-383.
13. Jabbour SA. Steroids and the surgical patient. Med Clin North Am. 2001; 85:1311-1317.
14. Hochberg Z, Pacak K, Chrousos GP. Endocrine withdrawal syndromes. Endocr Rev. 2003; 24:523-538.
15. Coursin DB, Wood KE. Corticosteroid supplementation for adrenal insufficiency. JAMA. 2002; 287:236-240.
16. Cooper MS, Stewart PM. Corticosteroid insufficiency in acutely ill patients. N Engl J Med. 2003; 348:727-734.
17. Endres M. Statins and stroke. J Cereb Blood Flow Metab. 2005; 25:1093-1110.
18. Heeschen C, Hamm CW, Laufs U, Snapinn S, Bohm M, White HD. Withdrawal of statins increases event rates in patients with acute coronary syndromes. Circulation. 2002; 105:1446-1452.
19. Singhal AB, Topcuoglu MA, Dorer DJ, Ogilvy CS, Carter BS, Koroshetz WJ. SSRI and statin use increases the risk for vasospasm after subarachnoid hemorrhage. Neurology. 2005; 64:1008-1013.
20. Mekontso-Dessap A, Brun-Buisson C. Statins: the next step in adjuvant therapy for sepsis? Intensive Care Med. 2006; 32:11-14.
21. McGowan MP. There is no evidence for an increase in acute coronary syndromes after short-term abrupt discontinuation of statins in stable cardiac patients. Circulation. 2004; 110:2333-2335.
22. Miller NS, Gold MS. Management of withdrawal syndromes and relapse prevention in drug and alcohol dependence. Am Fam Physician. 1998; 58:139-146.
23. Ang-Lee MK, Moss J, Yuan CS. Herbal medicines and perioperative care. JAMA. 2001; 286:208-216.